Benzinga | Jan 27, 2021 04:17PM EST

Edwards Lifesciences Q4 Adj. EPS $0.50 Misses $0.53 Estimate, Sales $1.19B Beat $1.19B Estimate

Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.50 per share which missed the analyst consensus estimate of $0.53 by 5.66 percent. This is a 65.75 percent decrease over earnings of $1.46 per share from the same period last year. The company reported quarterly sales of $1.19 billion which beat the analyst consensus estimate of $1.19 billion by 0.17 percent. This is a 1.53 percent increase over sales of $1.17 billion the same period last year.